Pacira BioSciences (STU:82P) Marketable Securities : €130.5 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Pacira BioSciences Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Pacira BioSciences's Marketable Securities for the quarter that ended in Mar. 2024 was €130.5 Mil.

Pacira BioSciences's annual Marketable Securities increased from Dec. 2021 (€62.7 Mil) to Dec. 2022 (€174.2 Mil) but then declined from Dec. 2022 (€174.2 Mil) to Dec. 2023 (€114.9 Mil).

Pacira BioSciences Marketable Securities Historical Data

The historical data trend for Pacira BioSciences's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacira BioSciences Marketable Securities Chart

Pacira BioSciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

192.35

346.64

62.69

174.18

114.89

Pacira BioSciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															129.32	123.64	127.50	114.89	130.49

Pacira BioSciences Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Pacira BioSciences (STU:82P) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Pacira BioSciences Marketable Securities Related Terms

Thank you for viewing the detailed overview of Pacira BioSciences's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Pacira BioSciences (STU:82P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pacira BioSciences Inc (STU:82P) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

PCRX:USA 82P:Germany

Address

5401 West Kennedy Boulevard, Suite 890, Tampa, FL, USA, 33609

Website

https://www.pacira.com

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time.

Pacira BioSciences (STU:82P) Headlines

No Headlines